$NVRO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NEVRO CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in NEVRO CORP. Get notifications about new insider transactions in NEVRO CORP for free.
Page: < prev 1 ... 2 3 4 5 6 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 06 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales & Marke ... | Sell | S | 64.74 | 1,060 | 68,627 | 37,853 | 38.9 K to 37.9 K (-2.72 %) |
May 06 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales & Marke ... | Buy | M | 3.60 | 1,500 | 5,400 | 38,913 | 37.4 K to 38.9 K (+4.01 %) |
Apr 05 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales & Marke ... | Option Exercise | M | 3.60 | 8,767 | 31,561 | 92,108 | |
Apr 05 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales & Marke ... | Sell | S | 61.95 | 4,733 | 293,208 | 37,413 | 42.1 K to 37.4 K (-11.23 %) |
Apr 05 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales & Marke ... | Sell | S | 61.16 | 4,034 | 246,725 | 42,146 | 46.2 K to 42.1 K (-8.74 %) |
Apr 05 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales & Marke ... | Buy | M | 3.60 | 8,767 | 31,561 | 46,180 | 37.4 K to 46.2 K (+23.43 %) |
Apr 05 2016 | NVRO | NEVRO CORP | Elghandour Rami | President | Option Exercise | M | 3.60 | 7,000 | 25,200 | 123,390 | |
Apr 05 2016 | NVRO | NEVRO CORP | Elghandour Rami | President | Sell | S | 61.28 | 2,500 | 153,208 | 64,180 | 66.7 K to 64.2 K (-3.75 %) |
Apr 05 2016 | NVRO | NEVRO CORP | Elghandour Rami | President | Sell | S | 60.83 | 4,500 | 273,727 | 66,680 | 71.2 K to 66.7 K (-6.32 %) |
Apr 05 2016 | NVRO | NEVRO CORP | Elghandour Rami | President | Buy | M | 3.60 | 7,000 | 25,200 | 71,180 | 64.2 K to 71.2 K (+10.91 %) |
Mar 21 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Option Exercise | M | 1.44 | 25,500 | 36,720 | 37,404 | |
Mar 21 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Buy | M | 1.44 | 25,500 | 36,720 | 30,000 | 4.5 K to 30 K (+566.67 %) |
Mar 16 2016 | NVRO | NEVRO CORP | Schmitz Patrick | Vice President, Ope ... | Option Exercise | A | 57.89 | 20,000 | 1,157,800 | 20,000 | |
Mar 16 2016 | NVRO | NEVRO CORP | Schmitz Patrick | Vice President, Ope ... | Grant | A | 0.00 | 4,500 | 0 | 4,500 | 0 to 4.5 K |
Mar 11 2016 | NVRO | NEVRO CORP | Elghandour Rami | President | Option Exercise | A | 54.50 | 67,432 | 3,675,044 | 67,432 | |
Mar 11 2016 | NVRO | NEVRO CORP | Elghandour Rami | President | Option Exercise | A | 54.50 | 202,294 | 11,025,023 | 202,294 | |
Mar 11 2016 | NVRO | NEVRO CORP | Elghandour Rami | President | Option Exercise | M | 3.60 | 485 | 1,746 | 130,390 | |
Mar 11 2016 | NVRO | NEVRO CORP | Elghandour Rami | President | Grant | A | 0.00 | 15,924 | 0 | 64,180 | 48.3 K to 64.2 K (+33.00 %) |
Mar 11 2016 | NVRO | NEVRO CORP | Elghandour Rami | President | Grant | A | 0.00 | 47,771 | 0 | 48,256 | 485 to 48.3 K (+9,849.69 %) |
Mar 11 2016 | NVRO | NEVRO CORP | Elghandour Rami | President | Buy | M | 3.60 | 485 | 1,746 | 485 | 0 to 485 |
Mar 07 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales & Marke ... | Option Exercise | M | 3.60 | 37,000 | 133,200 | 100,875 | |
Mar 07 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales & Marke ... | Buy | M | 3.60 | 37,000 | 133,200 | 37,413 | 413 to 37.4 K (+8,958.84 %) |
Mar 03 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Chief Executive Off ... | Sell | S | 58.99 | 50 | 2,950 | 30,921 | 31 K to 30.9 K (-0.16 %) |
Mar 03 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Chief Executive Off ... | Sell | S | 57.75 | 407 | 23,503 | 30,971 | 31.4 K to 31 K (-1.30 %) |
Mar 03 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Chief Executive Off ... | Sell | S | 56.22 | 150 | 8,433 | 31,378 | 31.5 K to 31.4 K (-0.48 %) |
Mar 03 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Chief Executive Off ... | Sell | S | 55.01 | 6,059 | 333,296 | 31,528 | 37.6 K to 31.5 K (-16.12 %) |
Mar 03 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Chief Executive Off ... | Sell | S | 58.99 | 50 | 2,950 | 99,220 | 99.3 K to 99.2 K (-0.05 %) |
Mar 03 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Chief Executive Off ... | Sell | S | 57.75 | 408 | 23,560 | 99,270 | 99.7 K to 99.3 K (-0.41 %) |
Mar 03 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Chief Executive Off ... | Sell | S | 56.22 | 150 | 8,433 | 99,678 | 99.8 K to 99.7 K (-0.15 %) |
Mar 03 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Chief Executive Off ... | Sell | S | 55.01 | 6,058 | 333,241 | 99,828 | 105.9 K to 99.8 K (-5.72 %) |
Mar 03 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Chief Executive Off ... | Sell | S | 59.06 | 200 | 11,813 | 552,587 | 552.8 K to 552.6 K (-0.04 %) |
Mar 03 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Chief Executive Off ... | Sell | S | 57.80 | 1,465 | 84,675 | 552,787 | 554.3 K to 552.8 K (-0.26 %) |
Mar 03 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Chief Executive Off ... | Sell | S | 56.80 | 8,688 | 493,495 | 554,252 | 562.9 K to 554.3 K (-1.54 %) |
Mar 03 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Chief Executive Off ... | Sell | S | 55.10 | 16,314 | 898,839 | 562,940 | 579.3 K to 562.9 K (-2.82 %) |
Mar 03 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Option Exercise | M | 1.44 | 10,000 | 14,400 | 62,904 | |
Mar 03 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Option Exercise | M | 1.44 | 4,500 | 6,480 | 72,904 | |
Mar 03 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Sell | S | 59.06 | 100 | 5,906 | 4,500 | 4.6 K to 4.5 K (-2.17 %) |
Mar 03 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Sell | S | 57.68 | 600 | 34,608 | 4,600 | 5.2 K to 4.6 K (-11.54 %) |
Mar 03 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Sell | S | 56.74 | 3,314 | 188,023 | 5,200 | 8.5 K to 5.2 K (-38.92 %) |
Mar 03 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Sell | S | 56.07 | 3,100 | 173,803 | 8,514 | 11.6 K to 8.5 K (-26.69 %) |
Mar 03 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Sell | S | 54.81 | 1,384 | 75,858 | 11,614 | 13 K to 11.6 K (-10.65 %) |
Mar 03 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Sell | S | 53.90 | 1,202 | 64,785 | 12,998 | 14.2 K to 13 K (-8.46 %) |
Mar 03 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Sell | S | 52.30 | 300 | 15,689 | 14,200 | 14.5 K to 14.2 K (-2.07 %) |
Mar 03 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Buy | M | 1.44 | 10,000 | 14,400 | 14,500 | 4.5 K to 14.5 K (+222.22 %) |
Mar 03 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Buy | M | 1.44 | 4,500 | 6,480 | 4,500 | 0 to 4.5 K |
Jan 13 2016 | NVRO | NEVRO CORP | Alleavitch Doug | VP, Quality and Ope ... | Sell | S | 70.00 | 1,000 | 70,000 | 10,470 | 11.5 K to 10.5 K (-8.72 %) |
Jan 13 2016 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Option Exercise | M | 1.44 | 7,987 | 11,501 | 39,422 | |
Jan 13 2016 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Sell | S | 72.00 | 2,000 | 144,000 | 470 | 2.5 K to 470 (-80.97 %) |
Jan 13 2016 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Sell | S | 71.00 | 2,000 | 142,000 | 2,470 | 4.5 K to 2.5 K (-44.74 %) |
Jan 13 2016 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Sell | S | 70.00 | 3,987 | 279,090 | 4,470 | 8.5 K to 4.5 K (-47.14 %) |
Jan 13 2016 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Buy | M | 1.44 | 7,987 | 11,501 | 8,457 | 470 to 8.5 K (+1,699.36 %) |
Jan 06 2016 | NVRO | NEVRO CORP | Alleavitch Doug | VP, Quality and Ope ... | Sell | S | 66.72 | 1,014 | 67,652 | 6,690 | 7.7 K to 6.7 K (-13.16 %) |
Jan 06 2016 | NVRO | NEVRO CORP | Alleavitch Doug | VP, Quality and Ope ... | Sell | S | 65.91 | 500 | 32,956 | 7,704 | 8.2 K to 7.7 K (-6.09 %) |
Jan 06 2016 | NVRO | NEVRO CORP | Alleavitch Doug | VP, Quality and Ope ... | Sell | S | 66.77 | 700 | 46,737 | 11,470 | 12.2 K to 11.5 K (-5.75 %) |
Jan 06 2016 | NVRO | NEVRO CORP | Alleavitch Doug | VP, Quality and Ope ... | Sell | S | 65.86 | 300 | 19,759 | 12,170 | 12.5 K to 12.2 K (-2.41 %) |
Dec 18 2015 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Option Exercise | M | 1.44 | 13 | 19 | 47,409 | |
Dec 18 2015 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Sell | S | 69.00 | 13 | 897 | 470 | 483 to 470 (-2.69 %) |
Dec 18 2015 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Buy | M | 1.44 | 13 | 19 | 483 | 470 to 483 (+2.77 %) |
Dec 16 2015 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Option Exercise | M | 1.44 | 3,000 | 4,320 | 47,422 | |
Dec 16 2015 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Sell | S | 68.00 | 1,000 | 68,000 | 470 | 1.5 K to 470 (-68.03 %) |
Dec 16 2015 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Sell | S | 66.58 | 2,000 | 133,150 | 1,470 | 3.5 K to 1.5 K (-57.64 %) |
Dec 16 2015 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Buy | M | 1.44 | 3,000 | 4,320 | 3,470 | 470 to 3.5 K (+638.30 %) |
Dec 14 2015 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Option Exercise | M | 1.44 | 1,000 | 1,440 | 50,422 | |
Dec 14 2015 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Option Exercise | M | 0.96 | 312 | 300 | 0 | |
Dec 14 2015 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Option Exercise | M | 0.96 | 302 | 290 | 0 | |
Dec 14 2015 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Sell | S | 65.00 | 1,614 | 104,910 | 470 | 2.1 K to 470 (-77.45 %) |
Dec 14 2015 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Buy | M | 1.44 | 1,000 | 1,440 | 2,084 | 1.1 K to 2.1 K (+92.25 %) |
Dec 14 2015 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Buy | M | 0.96 | 312 | 300 | 1,084 | 772 to 1.1 K (+40.41 %) |
Dec 14 2015 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Buy | M | 0.96 | 302 | 290 | 772 | 470 to 772 (+64.26 %) |
Dec 09 2015 | NVRO | NEVRO CORP | Elghandour Rami | President | Option Exercise | M | 3.60 | 3,500 | 12,600 | 130,875 | |
Dec 09 2015 | NVRO | NEVRO CORP | Elghandour Rami | President | Sell | S | 62.22 | 913 | 56,808 | 0 | 913 to 0 (-100.00 %) |
Dec 09 2015 | NVRO | NEVRO CORP | Elghandour Rami | President | Sell | S | 61.67 | 2,587 | 159,550 | 913 | 3.5 K to 913 (-73.91 %) |
Dec 09 2015 | NVRO | NEVRO CORP | Elghandour Rami | President | Buy | M | 3.60 | 3,500 | 12,600 | 3,500 | 0 to 3.5 K |
Dec 04 2015 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Option Exercise | M | 0.96 | 1,000 | 960 | 302 | |
Dec 04 2015 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Sell | S | 64.00 | 1,000 | 64,000 | 470 | 1.5 K to 470 (-68.03 %) |
Dec 04 2015 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Buy | M | 0.96 | 1,000 | 960 | 1,470 | 470 to 1.5 K (+212.77 %) |
Dec 03 2015 | NVRO | NEVRO CORP | Alleavitch Doug | VP, Quality and Ope ... | Option Exercise | A | 63.23 | 21,000 | 1,327,830 | 21,000 | |
Dec 03 2015 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales & Marke ... | Option Exercise | A | 63.23 | 13,300 | 840,959 | 13,300 | |
Dec 03 2015 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Option Exercise | A | 63.23 | 44,500 | 2,813,735 | 44,500 | |
Dec 03 2015 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Chief Executive Off ... | Option Exercise | A | 63.23 | 100,000 | 6,323,000 | 100,000 | |
Dec 03 2015 | NVRO | NEVRO CORP | Behbahani Ali | Director | Buy | J | 0.00 | 3 | 0 | 25 | 22 to 25 (+13.64 %) |
Dec 03 2015 | NVRO | NEVRO CORP | Behbahani Ali | Director | Buy | J | 0.00 | 22 | 0 | 22 | 0 to 22 |
Dec 02 2015 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Option Exercise | A | 63.23 | 14,000 | 885,220 | 14,000 | |
Dec 02 2015 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Option Exercise | M | 0.96 | 2,000 | 1,920 | 1,302 | |
Dec 02 2015 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Option Exercise | M | 0.96 | 6,000 | 5,760 | 3,302 | |
Dec 02 2015 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Sell | S | 63.00 | 1,000 | 63,000 | 470 | 1.5 K to 470 (-68.03 %) |
Dec 02 2015 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Sell | S | 62.00 | 1,000 | 62,000 | 1,470 | 2.5 K to 1.5 K (-40.49 %) |
Dec 02 2015 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Buy | M | 0.96 | 2,000 | 1,920 | 2,470 | 470 to 2.5 K (+425.53 %) |
Dec 02 2015 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Sell | S | 61.00 | 1,000 | 61,000 | 470 | 1.5 K to 470 (-68.03 %) |
Dec 02 2015 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Sell | S | 60.00 | 1,000 | 60,000 | 1,470 | 2.5 K to 1.5 K (-40.49 %) |
Dec 02 2015 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Sell | S | 59.00 | 1,000 | 59,000 | 2,470 | 3.5 K to 2.5 K (-28.82 %) |
Dec 02 2015 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Sell | S | 58.00 | 1,000 | 58,000 | 3,470 | 4.5 K to 3.5 K (-22.37 %) |
Dec 02 2015 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Sell | S | 57.00 | 1,000 | 57,000 | 4,470 | 5.5 K to 4.5 K (-18.28 %) |
Dec 02 2015 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Sell | S | 56.00 | 1,000 | 56,000 | 5,470 | 6.5 K to 5.5 K (-15.46 %) |
Dec 02 2015 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Buy | M | 0.96 | 6,000 | 5,760 | 6,470 | 470 to 6.5 K (+1,276.60 %) |
Dec 02 2015 | NVRO | NEVRO CORP | Elghandour Rami | President | Option Exercise | A | 63.23 | 49,500 | 3,129,885 | 49,500 | |
Dec 02 2015 | NVRO | NEVRO CORP | Elghandour Rami | President | Option Exercise | M | 3.60 | 3,500 | 12,600 | 134,375 | |
Dec 02 2015 | NVRO | NEVRO CORP | Elghandour Rami | President | Sell | S | 60.00 | 3,500 | 210,000 | 0 | 3.5 K to 0 (-100.00 %) |
Dec 02 2015 | NVRO | NEVRO CORP | Elghandour Rami | President | Buy | M | 3.60 | 3,500 | 12,600 | 3,500 | 0 to 3.5 K |
Nov 25 2015 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Option Exercise | M | 0.96 | 1,000 | 960 | 9,302 | |
Nov 25 2015 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Sell | S | 55.00 | 1,000 | 55,000 | 470 | 1.5 K to 470 (-68.03 %) |
Nov 25 2015 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Buy | M | 0.96 | 1,000 | 960 | 1,470 | 470 to 1.5 K (+212.77 %) |
Nov 24 2015 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 53.48 | 540 | 28,880 | 34,934 | 35.5 K to 34.9 K (-1.52 %) |
Nov 24 2015 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 53.48 | 24,460 | 1,308,150 | 1,582,167 | 1.6 M to 1.6 M (-1.52 %) |
Nov 24 2015 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Option Exercise | M | 0.96 | 1,000 | 960 | 10,302 | |
Nov 24 2015 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Sell | S | 54.00 | 1,000 | 54,000 | 470 | 1.5 K to 470 (-68.03 %) |
Nov 24 2015 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Buy | M | 0.96 | 1,000 | 960 | 1,470 | 470 to 1.5 K (+212.77 %) |
Nov 19 2015 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 53.16 | 696 | 36,999 | 35,474 | 36.2 K to 35.5 K (-1.92 %) |
Nov 19 2015 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 52.08 | 2,040 | 106,237 | 36,170 | 38.2 K to 36.2 K (-5.34 %) |
Nov 19 2015 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 53.16 | 31,496 | 1,674,305 | 1,606,627 | 1.6 M to 1.6 M (-1.92 %) |
Nov 19 2015 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 52.08 | 92,400 | 4,811,896 | 1,638,123 | 1.7 M to 1.6 M (-5.34 %) |
Nov 19 2015 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 51.94 | 1,045 | 54,276 | 38,210 | 39.3 K to 38.2 K (-2.66 %) |
Nov 19 2015 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 51.94 | 47,323 | 2,457,909 | 1,730,523 | 1.8 M to 1.7 M (-2.66 %) |
Nov 19 2015 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Option Exercise | M | 18.00 | 4,615 | 83,070 | 51,899 | |
Nov 19 2015 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Option Exercise | M | 3.60 | 4,070 | 14,652 | 44,804 | |
Nov 19 2015 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Option Exercise | M | 3.60 | 869 | 3,128 | 62,940 | |
Nov 19 2015 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Option Exercise | M | 1.44 | 10,446 | 15,042 | 77,404 | |
Nov 19 2015 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Sell | S | 52.01 | 1,500 | 78,012 | 0 | 1.5 K to 0 (-100.00 %) |
Nov 19 2015 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Sell | S | 51.24 | 18,500 | 947,877 | 1,500 | 20 K to 1.5 K (-92.50 %) |
Nov 19 2015 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Buy | M | 18.00 | 4,615 | 83,070 | 20,000 | 15.4 K to 20 K (+30.00 %) |
Nov 19 2015 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Buy | M | 3.60 | 4,070 | 14,652 | 15,385 | 11.3 K to 15.4 K (+35.97 %) |
Nov 19 2015 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Buy | M | 3.60 | 869 | 3,128 | 11,315 | 10.4 K to 11.3 K (+8.32 %) |
Nov 19 2015 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Buy | M | 1.44 | 10,446 | 15,042 | 10,446 | 0 to 10.4 K |
Nov 18 2015 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Chief Executive Off ... | Sell | S | 50.52 | 6,667 | 336,810 | 111,199 | 117.9 K to 111.2 K (-5.66 %) |
Nov 18 2015 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Chief Executive Off ... | Sell | S | 50.52 | 6,667 | 336,810 | 37,587 | 44.3 K to 37.6 K (-15.07 %) |
Nov 18 2015 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Chief Executive Off ... | Sell | S | 50.52 | 26,667 | 1,347,188 | 573,941 | 600.6 K to 573.9 K (-4.44 %) |
Nov 16 2015 | NVRO | NEVRO CORP | Vale Brad | Director | Buy | P | 50.76 | 2,000 | 101,520 | 2,000 | 0 to 2 K |
Sep 21 2015 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Option Exercise | M | 0.96 | 4,000 | 3,840 | 11,302 | |
Sep 21 2015 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Sell | S | 53.00 | 1,000 | 53,000 | 0 | 1,000 to 0 (-100.00 %) |
Sep 21 2015 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Sell | S | 52.00 | 1,000 | 52,000 | 1,000 | 2 K to 1,000 (-50.00 %) |
Sep 21 2015 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Sell | S | 50.00 | 1,000 | 50,000 | 2,000 | 3 K to 2 K (-33.33 %) |
Sep 21 2015 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Sell | S | 48.00 | 1,000 | 48,000 | 3,000 | 4 K to 3 K (-25.00 %) |
Sep 21 2015 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Buy | M | 0.96 | 4,000 | 3,840 | 4,000 | 0 to 4 K |
Sep 03 2015 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Chief Executive Off ... | Sell | S | 45.30 | 6,667 | 302,030 | 117,866 | 124.5 K to 117.9 K (-5.35 %) |
Sep 03 2015 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Chief Executive Off ... | Sell | S | 45.30 | 6,667 | 302,029 | 44,254 | 50.9 K to 44.3 K (-13.09 %) |
Sep 03 2015 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Chief Executive Off ... | Sell | S | 45.02 | 26,667 | 1,200,572 | 600,608 | 627.3 K to 600.6 K (-4.25 %) |
Jul 01 2015 | NVRO | NEVRO CORP | Earnhardt Lisa D | Director | Option Exercise | A | 53.59 | 5,853 | 313,662 | 5,853 | |
Jun 17 2015 | NVRO | NEVRO CORP | BAY CITY CAPITAL LLC | Sell | S | 47.94 | 10,378 | 497,521 | 36,403 | 46.8 K to 36.4 K (-22.18 %) | |
Jun 17 2015 | NVRO | NEVRO CORP | BAY CITY CAPITAL LLC | Sell | S | 47.94 | 481,457 | 23,081,049 | 1,688,976 | 2.2 M to 1.7 M (-22.18 %) | |
Jun 08 2015 | NVRO | NEVRO CORP | JOHNSON & JOHNSON | 10% Owner | Sell | S | 47.94 | 1,010,265 | 48,432,104 | 2,066,740 | 3.1 M to 2.1 M (-32.83 %) |
Jun 08 2015 | NVRO | NEVRO CORP | PLIAM NATHAN B | Director | Sell | S | 47.94 | 10,378 | 497,521 | 36,403 | 46.8 K to 36.4 K (-22.18 %) |
Jun 08 2015 | NVRO | NEVRO CORP | PLIAM NATHAN B | Director | Sell | S | 47.94 | 481,457 | 23,081,049 | 1,688,976 | 2.2 M to 1.7 M (-22.18 %) |
Jun 08 2015 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 47.94 | 8,500 | 407,490 | 39,255 | 47.8 K to 39.3 K (-17.80 %) |
Jun 08 2015 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 47.94 | 384,968 | 18,455,366 | 1,777,846 | 2.2 M to 1.8 M (-17.80 %) |
Jun 01 2015 | NVRO | NEVRO CORP | Behbahani Ali | Director | Option Exercise | A | 50.50 | 4,182 | 211,191 | 4,182 | |
Jun 01 2015 | NVRO | NEVRO CORP | PLIAM NATHAN B | Director | Option Exercise | A | 50.50 | 4,182 | 211,191 | 4,182 | |
Jun 01 2015 | NVRO | NEVRO CORP | McCormick Shawn | Director | Option Exercise | A | 50.50 | 4,182 | 211,191 | 4,182 | |
Jun 01 2015 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Option Exercise | A | 50.50 | 4,182 | 211,191 | 4,182 | |
Jun 01 2015 | NVRO | NEVRO CORP | Fischer Frank M | Director | Option Exercise | A | 50.50 | 4,182 | 211,191 | 4,182 | |
Jun 01 2015 | NVRO | NEVRO CORP | Vale Brad | Director | Option Exercise | A | 50.50 | 4,182 | 211,191 | 4,182 |